Press release
Vaccines Market: Growing Prevalence of Viral Infectious Diseases to Drive a 3.70% CAGR through 2031
Vaccines Market Size, Share, Growth Analysis, By Technology (Conjugate Vaccines, Recombinant Vaccines), By Type (Multivalent Vaccines, Monovalent Vaccines), By Disease Indication (Pneumococcal Disease, Hepatitis), By Route of Administration (Oral Route, Intranasal Route NAS), By End User (Adult Vaccines, Pediatric Vaccines), By Region - Industry Forecast 2024-2031Vaccines Market [https://www.skyquestt.com/report/vaccines-market] size was valued at USD 72 billion in 2022 and is poised to grow from USD 74.66 billion in 2023 to USD 99.85 billion by 2031, growing at a CAGR of 3.70% during the forecast period (2024-2031).
Vaccines are the most powerful and cost-effective way to protect millions of people worldwide. They have the potential to transform health by removing the burden of life-threatening infectious diseases from the populations of the developing countries. World Health Organization says vaccination awareness and government policy strains have helped prevent 2-3 million deaths per year. Further investments, as well as the corporate mergers and consolidations, increase production and sales worldwide. One of the biggest challenges organizations and companies face worldwide is trial and error in effectively combating malaria, HIV, and tuberculosis pharmaceutical companies.
Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/vaccines-market
Competitive Environment in the Vaccines Market: An Enlarged View
The vaccines marketplace is a dynamic and competitive environment, with the huge installed pharmaceuticals and rising biotechnology companies competing for market proportion. Key marketplace players are focusing on developing the new vaccines, expanding product traces, and forming the strategic partnerships to reinforce their positions on this developing segment.
Dominance of Leading Pharmaceutical Companies
The global vaccine market is dominated by pharmaceutical giants such as Pfizer, GlaxoSmithKline (GSK), Sanofi and Merck. These companies have abundant resources, large research and development (R&D) capabilities, and the well-established distribution networks that give them a competitive advantage. Their ability to develop, test and bring vaccines to market has positioned them as leaders, in response to the public health emergencies.
For a tailored report, contact us to request a free customization:
https://www.skyquestt.com/speak-with-analyst/vaccines-market
Strategic Cooperation and Partnership
Strategic collaborations between the companies are an important determinant in the vaccines market. Established pharmaceutical agencies to pool resources and expertise in partnerships with the smaller biotechnology companies, research institutes, and government agencies. These collaborations have been critical to speed up vaccine development and production.
February 2024: UNICEF expanded cooperation with the Ministry of Health in Azerbaijan to increase childhood immunization coverage.
February 2024: UNICEF Africa and CDC expand their collaboration to strengthen supply chain management, primary health care and immunization coverage among African children.
January 2023: Bharat Biotech offered iNCOVAC, a domestically manufactured COVID-19 oral vaccine for adults over 18 years.
August 2022: GSK acquired Affinivax, Inc., a clinical biopharmaceutical company. Through this acquisition, the company aims to strengthen its manufacturing portfolio.
Purchase now to gain valuable insights and stay informed:
https://www.skyquestt.com/buy-now/vaccines-market
This report covers the following segments:
A. Age
* Pediatric
* Adult
B. Disease
* Cancer
* Hepatitis
* Pneumococcal disease
* DTP
* Influenza
* Human Papilloma Virus
* Meningococcal Disease
* Polio
* Rotavirus
* COVID-19
* Others
C. Technology
* Conjugated
* Live
* Inactivated
* Recombinant
* Toxoid
* Others
This report covers the following players:
* GlaxoSmithKline
* Abbott
* Astellas Pharma, Inc.
* AstraZeneca
* Serum Institute of India
* CSL Limited
* Emergent BioSolutions, Inc.
* Merck & Co. Inc.
* Novavax
* Pfizer
* Sanofi
Pioneering the Future of Vaccines and Innovations Shaping Global Health
The vaccines market is at the forefront of innovation, with advances in mRNA technology, nanotechnology and viral vector platforms changing the landscape as global health challenges, such as emerging infectious diseases and pandemic threats. Furthermore, vaccination coverage and personalized vaccine delivery methods highlight the ongoing progress in vaccine developments. The future of vaccination marks a new era of global health improvement driven by scientific advances and collaborative efforts of the promise.
To read the full report, please visit: https://www.skyquestt.com/report/vaccines-market
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=vaccines-market-growing-prevalence-of-viral-infectious-diseases-to-drive-a-370-cagr-through-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/vaccines-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccines Market: Growing Prevalence of Viral Infectious Diseases to Drive a 3.70% CAGR through 2031 here
News-ID: 3736611 • Views: …
More Releases from ABNewswire
Help Clinic Canada Highlights Invisible Grief as More Canadians Turn to Online T …
Invisible and ambiguous grief is increasingly discussed in mental health care, particularly when losses lack clear endings. Help Clinic Canada notes growing demand for online therapy in Canada as individuals seek support for emotional adjustment during periods of change.
Invisible grief is receiving increased attention within mental health care as more Canadians seek online therapy for emotional distress that does not stem from death or a clearly defined loss. Help Clinic…
Trauma Therapist Institute Announces March Trauma Training on Treating Dissociat …
Featuring Renowned Trauma Educator Jamie Marich, Ph.D., LPCC-S, REAT
DENVER, CO - The Trauma Therapist Institute Copyright [https://www.traumatherapistinstitute.com/] (TTI), a leading provider of advanced trauma training for mental health professionals, is now enrolling participants for Clinical Competencies in Treating Dissociative Identities: Bridging Lived Experience and Science for the Trauma Therapist [https://www.traumatherapistinstitute.com/Clinical-Competencies-in-Treating-Dissociative-Identities-Non-EMDR], a live virtual training designed for clinicians working with complex trauma and dissociative presentations.
Led by internationally recognized trauma educator and…
J. Elise Boutique Celebrates 10 Years of Elevated, Bold Fashion for Confident Wo …
Founded by a mother of six, J. Elise Boutique marks a decade of empowering women through curated capsule drops and statement-making style.
As J. Elise Boutique approaches its 10-year anniversary, the woman-owned fashion brand reflects on a decade of growth rooted in clarity, resilience, and elevated design.
Founded nearly ten years ago, J. Elise Boutique was built to serve fashion-forward women seeking bold, luxury-inspired pieces without traditional luxury pricing. What began as…
7 Best B2B SaaS SEO Agencies Focused on Revenue (Not Just Traffic)
Image: https://www.abnewswire.com/upload/2026/02/cd6ee2e205d1ea2deaaa29925ad249ac.jpg
For the better part of a decade, the mandate for B2B SaaS marketing was dangerously simple: Get more traffic.
The logic was linear. If you could rank for high-volume keywords, the law of averages suggested that demos and revenue would follow. But as we settle into 2026, that equation has broken.
We are witnessing a fundamental decoupling of "search volume" and "commercial intent."
Marketing leaders are facing a new, uncomfortable reality: traffic…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
